Phenotypic properties of transmitted founder HIV-1

Nicholas F. Parrish(University of Pennsylvania), Feng Gao(International Vaccine Institute), Hui Li, Elena E. Giorgi(Los Alamos National Laboratory), Hannah J. Barbian(University of Pennsylvania), Erica H. Parrish, Lara Zajic, Shilpa S. Iyer(University of Pennsylvania), Julie M. Decker(University of Alabama at Birmingham), Amit Kumar(International Vaccine Institute), Bhavna Hora(International Vaccine Institute), Anna Berg(International Vaccine Institute), Fangping Cai(International Vaccine Institute), Jennifer Hopper(International Vaccine Institute), Thomas N. Denny(International Vaccine Institute), Haitao Ding(University of Alabama at Birmingham), Christina Ochsenbauer(University of Alabama at Birmingham), John C. Kappes(University of Alabama at Birmingham), Rachel P. Galimidi, Anthony P. West, Pamela J. Björkman(California Institute of Technology), Craig B. Wilen(University of Pennsylvania), Robert W. Doms(Children's Hospital of Philadelphia), Meagan P. O’Brien, Nina Bhardwaj(New York University), Persephone Borrow(John Radcliffe Hospital), Barton F. Haynes(International Vaccine Institute), Mark Muldoon(University of Manchester), James Theiler(Los Alamos National Laboratory), Bette Korber(Los Alamos National Laboratory), George M. Shaw(University of Pennsylvania), Beatrice H. Hahn(University of Pennsylvania)
Proceedings of the National Academy of Sciences
March 29, 2013
Cited by 438Open Access
Full Text

Abstract

Defining the virus-host interactions responsible for HIV-1 transmission, including the phenotypic requirements of viruses capable of establishing de novo infections, could be important for AIDS vaccine development. Previous analyses have failed to identify phenotypic properties other than chemokine receptor 5 (CCR5) and CD4+ T-cell tropism that are preferentially associated with viral transmission. However, most of these studies were limited to examining envelope (Env) function in the context of pseudoviruses. Here, we generated infectious molecular clones of transmitted founder (TF; n = 27) and chronic control (CC; n = 14) viruses of subtypes B (n = 18) and C (n = 23) and compared their phenotypic properties in assays specifically designed to probe the earliest stages of HIV-1 infection. We found that TF virions were 1.7-fold more infectious (P = 0.049) and contained 1.9-fold more Env per particle (P = 0.048) compared with CC viruses. TF viruses were also captured by monocyte-derived dendritic cells 1.7-fold more efficiently (P = 0.035) and more readily transferred to CD4+ T cells (P = 0.025). In primary CD4+ T cells, TF and CC viruses replicated with comparable kinetics; however, when propagated in the presence of IFN-α, TF viruses replicated to higher titers than CC viruses. This difference was significant for subtype B (P = 0.000013) but not subtype C (P = 0.53) viruses, possibly reflecting demographic differences of the respective patient cohorts. Together, these data indicate that TF viruses are enriched for higher Env content, enhanced cell-free infectivity, improved dendritic cell interaction, and relative IFN-α resistance. These viral properties, which likely act in concert, should be considered in the development and testing of AIDS vaccines.


Related Papers

No related papers found

Powered by citation graph analysis